Ken Griffin’s LifeMD LFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-826,936
Closed -$2.86M 13665
2025
Q4
$2.82M Buy
826,936
+169,112
+26% +$821K ﹤0.01% 5286
2025
Q3
$4.47M Buy
+657,824
New +$5.43M ﹤0.01% 4561
2025
Q2
Sell
-485,182
Closed -$4.58M 13941
2025
Q1
$2.64M Buy
485,182
+411,865
+562% +$2.34M ﹤0.01% 5001
2024
Q4
$363K Sell
73,317
-104,455
-59% -$548K ﹤0.01% 9275
2024
Q3
$932K Sell
177,772
-97,206
-35% -$560K ﹤0.01% 7011
2024
Q2
$1.89M Buy
274,978
+225,156
+452% +$2.06M ﹤0.01% 5424
2024
Q1
$512K Buy
49,822
+18,977
+62% +$140K ﹤0.01% 8342
2023
Q4
$256K Sell
30,845
-23,829
-44% -$171K ﹤0.01% 9480
2023
Q3
$342K Buy
54,674
+21,742
+66% +$94.2K ﹤0.01% 8900
2023
Q2
$143K Sell
32,932
-64,205
-66% -$143K ﹤0.01% 10411
2023
Q1
$165K Sell
97,137
-8,511
-8% -$15K ﹤0.01% 10481
2022
Q4
$205K Buy
105,648
+52,610
+99% +$118K ﹤0.01% 10094
2022
Q3
$104K Buy
53,038
+29,638
+127% +$70.7K ﹤0.01% 11055
2022
Q2
$47K Sell
23,400
-89,136
-79% -$221K ﹤0.01% 11970
2022
Q1
$397K Buy
112,536
+38,391
+52% +$136K ﹤0.01% 9922
2021
Q4
$287K Buy
74,145
+30,681
+71% +$145K ﹤0.01% 11023
2021
Q3
$270K Sell
43,464
-49,080
-53% -$419K ﹤0.01% 11291
2021
Q2
$1.09M Buy
92,544
+10,735
+13% +$124K ﹤0.01% 8144
2021
Q1
$1.29M Buy
+81,809
New +$1.47M ﹤0.01% 7464

Other funds holding LFMD

Ken Griffin's LFMD Position: Q1 2026 in Review

Ken Griffin sold out of LifeMD (LFMD) in Q1 2026, closing a stake of 826,936 shares — an estimated $2.86M sold.

Ken Griffin first reported a position in LFMD in Q1 2021 and held it in 19 quarters. The position peaked at $4.47M in Q3 2025. 102 funds tracked by Wall St. Rank hold LFMD as of Q1 2026.

  • Ken Griffin reported no remaining LifeMD position as of Q1 2026 after selling out during the quarter.
  • Ken Griffin sold 826,936 LifeMD shares in Q1 2026, an estimated $2.86M.
  • Ken Griffin first reported a position in LifeMD in Q1 2021 and held it in 19 quarters.
  • Ken Griffin's LifeMD position peaked at $4.47M in Q3 2025.
  • 102 funds tracked by Wall St. Rank held LifeMD as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.